Persons with Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), display strong dysregulation of adaptive immunity, which underlies high risk of complications from infections, widespread autoimmunity, and poor vaccine responses. However, the mechanisms by which T21 dysregulates adaptive immunity acros...
Micah G. Donovan, N. Eduthan, Brian F. Niemeyer et al.· bioRxiv· 0 citations
Down syndrome, caused by trisomy 21, is characterized by chronic interferon-associated inflammation and immune dysregulation, yet the contribution of human secondary lymphoid organs to shaping this immune landscape remains unclear. Using multimodal single-cell and spatial profiling of human tonsils, we identify extensi...
J. Dutto, Jeremías Bustos, Lucía Boffelli et al.· bioRxiv· 0 citations
OBJECTIVE
To evaluate challenges in managing multisite, longitudinal, and multisystem clinical data for Down syndrome (DS) research and identify approaches to improve standardization and reuse.
METHODS
This report summarizes the outcomes and lessons learned from a NIH workshop convened by the INCLUDE Project to align...
J. Espinosa, Kate Burdekin, J. Auman et al.· Journal of Biomedical Inform...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.